Brooklyn Immunotherapeutics Inc (NQ: BTX )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 14, 2022 Add to My Watchlist

Other Filings

Form S-2/A
Source: SEC/Edgar
December 04, 2003
Form S-2/A
Source: SEC/Edgar
November 12, 2003
Form ARS
Source: SEC/Edgar
November 03, 2003
Form DEF 14A
Source: SEC/Edgar
November 02, 2003
Form SC 13D/A
Source: SEC/Edgar
October 08, 2003
Form 8-A12B
Source: SEC/Edgar
October 02, 2003
Form S-2
Source: SEC/Edgar
October 02, 2003
Form 8-K
Source: SEC/Edgar
June 25, 2003
Form SC 13D/A
Source: SEC/Edgar
April 27, 2003
Form 10-K/A
Source: SEC/Edgar
April 13, 2003
Form NT 10-K
Source: SEC/Edgar
March 31, 2003
Form 8-K
Source: SEC/Edgar
January 20, 2003
Form SC 13D/A
Source: SEC/Edgar
December 03, 2002
Form S-8
Source: SEC/Edgar
December 03, 2002
Form S-3/A
Source: SEC/Edgar
October 17, 2002
Form DEFA14A
Source: SEC/Edgar
September 30, 2002
Form ARS
Source: SEC/Edgar
September 29, 2002
Form DEF 14A
Source: SEC/Edgar
September 26, 2002
Form S-3
Source: SEC/Edgar
September 04, 2002
Form 10-Q/A
Source: SEC/Edgar
August 27, 2002
Form REGDEX
Source: SEC/Edgar
August 25, 2002
Form 8-K
Source: SEC/Edgar
July 10, 2002
Form SC 13D/A
Source: SEC/Edgar
July 02, 2002
Form SC 13D/A
Source: SEC/Edgar
June 02, 2002
Form 10-K/A
Source: SEC/Edgar
May 14, 2002
Form SC 13D/A
Source: SEC/Edgar
April 18, 2002
Form SC 13D
Source: SEC/Edgar
April 18, 2002
Form SC 13D/A
Source: SEC/Edgar
April 01, 2002
Form S-3/A
Source: SEC/Edgar
February 06, 2002
Form S-3/A
Source: SEC/Edgar
January 28, 2002
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.